COVID-19 Vaccine

COVID-19 Vaccine Eligibility Criteria

Last updated June 14, 2021

Eligibility Criteria: First and Second Doses

Last updated: June 14, 2021

All Manitobans aged 12 years and older are eligible to schedule a first dose vaccine appointment.

Manitoba has identified priority populations to have access to a second dose of COVID-19 vaccine first. The following people are eligible to schedule a second dose mRNA appointment, regardless of which vaccine they received for their first dose - Pfizer, Moderna or AstraZeneca/COVISHIELD:

  • Individuals who received their first dose on or before May 10, 2021 - updated
  • Indigenous people aged 12 and older.
  • Individuals aged 12 years and older with one or more priority conditions:
    • receiving hemodialysis OR peritoneal dialysis
    • liver cirrhosis due to any cause OR portal hypertension
    • severe heart failure 
    • cancers including solid tumor and blood (leukemia/lymphoma) who will or are receiving chemotherapy, immunosuppressive therapy or immune checkpoint inhibitors (e.g., nivolumab, pembrolizumab)
    • receiving one or more of the following medications: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors (cyclosporine, tacrolimus), chronic dose prednisone >=20mg/day, mycophenolate, and JAK inhibitors (e.g., tofacitinib)
    • have received or are on the list to receive a solid organ transplant
    • have received a stem cell transplant OR CAR-T therapy at least 3 months ago.
    • Down syndrome
    • Human immunodeficiency virus (HIV)
    • individuals receiving home care ≥ 4 times/week OR receiving 24/7 Community Living Disability Services supports (or as per family physician determination of equivalent levels of family support).

Eligible Manitobans can book second-dose Pfizer and Moderna appointments via the online system or by calling 1-844-MAN-VACC (1-844-626-8222).

Second Dose Appointments - Consent Forms

You will need to fill out and print a second consent form for your second dose appointment. This will ensure:

  • any changes in your health status can be reviewed before your second dose
  • providers will have the most up-to-date information in case you are getting a different vaccine
  • health professionals can review if you had an allergic reactions to a previous dose of the vaccine

Filling out the form in advance will also make it faster for you to get your vaccine. Click here to fill out and print the consent forms.

If you are a senior or have mobility issues and need help getting to your appointment at a clinic or pharmacy, call 211 for available transportation options in your area.

Information about Second Doses


It is recommended that people receive the same mRNA vaccine (Pfizer or Moderna) for their 1st and 2nd doses where possible. However, these vaccines are considered equivalent, and both are safe and effective.

When the same vaccine is not readily available, you can book an appointment for either Pfizer or Moderna as the 2nd dose. Individuals can also choose to book the earliest vaccine available to them for their 2nd dose.  You do not have to wait to receive the same brand of vaccine as your 1st dose.

Young people aged 12 to 17 must continue to receive Pfizer for both doses, as this is currently the only vaccine approved for use in this age group.

Due to ongoing vaccine supply challenges, there may be situations where the vaccine initially offered at the clinic will be changed to the vaccine that is currently available.

Getting a different second dose is safe and effective.

Individuals who received AstraZeneca/COVISHIELD vaccine for their first dose, are recommended to receive Pfizer or Moderna vaccine for their second dose. Individuals who cannot, or will not, receive a Pfizer or Moderna vaccine for their second dose, may be offered a second dose of AstraZeneca/COVISHIELD vaccine (while supplies last), provided they review the benefits and risks with their doctor or pharmacist AND meet the following criteria:

  • individuals aged 40 and over; OR
  • people aged 30 to 39 who meet one or more of the following conditions:
    • chronic renal disease including end stage renal disease undergoing hemodialysis OR peritoneal dialysis
    • chronic liver disease including cirrhosis due to any cause OR portal hypertension
    • chronic cardiovascular disease including heart failure, ventricular assist device, adult congenital heart disease coronary artery disease, malignant tachyarrythmia OR cardiomyopathies
    • COPD, pulmonary hypertension, pulmonary fibrosis, interstitial lung disease, severe/uncontrolled asthma OR cystic fibrosis
    • history of cerebral vascular accident with residual deficits
    • malignant hematologic disorders including leukemia and lymphoma OR clonal blood disorder
    • malignant neoplasms (solid tissue) who will receive or are currently receiving immunosuppressive therapy including chemotherapy
    • severe obesity (BMI ≥ 40)
    • receiving one or more of the following immunosuppressive therapies: B cell therapies (e.g., rituximab, ocrelizumab), cyclophosphamide, alemtuzumab, calcineurin inhibitors, chronic dose prednisone >=20mg/day, mycophenolate, sulfasalazine and JAK inhibitors (e.g., tofacitinib)
    • solid organ or hematopoietic stem cell transplant (candidate or recipient)
    • trisomy 21 (Down syndrome)
    • asplenia or hyposplenism (including sickle cell disease)
    • chronic neurologic OR neurodevelopmental conditions including cerebral palsy, Parkinson's disease, multiple sclerosis, ALS OR dementia (including Alzheimer's disease)
    • HIV (CD4 cell count ≥ 200 x 106/L and CD4 percentage ≥ 15%)
    • severe systemic autoimmune disorders (e.g., systemic lupus erythematosus, scleroderma, myocarditis, rheumatoid arthritis)
    • type 1 or 2 diabetes mellitus (poorly controlled and/or with complications)
    • active tuberculosis (current or previous) OR current latent tuberculosis (LTBI)
    • receiving other immunosuppressing therapy
    • individuals receiving home care OR receiving any level of Community Living disABILITY Services supports (or as per family physician determination of equivalent levels of family support).

Supplies of the AstraZeneca/COVISHIELD vaccine are limited and are only available at select doctor's offices or pharmacies. Go to or contact a doctor's office or pharmacy nearest you for information on supply.

Information about booking a second-dose appointment

To book a second-dose appointment, individuals must be eligible to schedule a second dose appointment AND must meet the minimum period of time required between first and second doses. To book second-dose appointments, individuals should have received a dose of Pfizer, Moderna or AstraZeneca/COVISHIELD at least 28 days prior to their second dose appointment. While not required, it is recommended to wait at least 8 weeks after receiving a 1st dose of AstraZeneca/COVIDSHIELD before receiving a 2nd dose of any vaccine.

To book a second dose appointment, you will need to know when you received your first dose of COVID-19 vaccine and the type of vaccine you received - Pfizer, Moderna or AstraZeneca/COVISHIELD. If you do not recall this information and you have a Manitoba Health card, go to: to access your personal information. If you do not have a Manitoba Health card, contact your local public health office for your immunization record. A listing of public health offices is available at:

Only individuals who are eligible for a second-dose can call or book an appointment online for immunization. You will be screened to ensure you meet current eligibility.


Where can I get a first or second dose COVID-19 vaccine? How can I book my appointment?

You can get your first or second dose of Pfizer or Moderna vaccine at a super-site, pop-up clinic, or a doctor's office or pharmacy that is accepting appointments.

  • * Vaccine appointments at super-sites or pop-up clinics can be booked by using the online system or by calling 1-844-MAN-VACC (1-844-626-8222). To book your vaccine appointment online, you'll need to create an account with your email address and your 9-digit personal health identification number (PHIN) on your Manitoba Health Card. You can link more than one person to the same account, so that you can also book for family members and loved ones. If you don't have an email address or health card number, the call centre continues to be available at 1-844-626-8222 (1-844-MAN-VACC) to book appointments at supersites and pop-up clinics. Daily hours of operation are from 6:00 a.m. to 8:00 p.m.

  • To find the nearest doctor's office or pharmacy with available vaccine doses, visit: or, contact your local doctor's office or pharmacy. You will need to contact the doctor's office or pharmacy to book your appointment.

If you are a senior or have mobility issues and need help getting to your appointment at a clinic or pharmacy, call 211 for available transportation options in your area.

Vaccinated While Away? Report Your Vaccine Today!

Individuals who received their COVID-19 vaccine outside of the province should have their vaccination information added into Manitoba's immunization system.

In order to do this, you will need proof of immunization from the jurisdiction where you received your vaccine.

If the vaccine you received is eligible for use in Canada, you can then bring this proof of immunization to a public health office. The office will enter this information to ensure that your primary care physician and our public health teams can have access to your immunization records.

If you only received one dose of a vaccine, this process will ensure that you receive your second dose in Manitoba at the proper time. It also allows us to know the exact number of individuals in Manitoba that are vaccinated. Knowing this information is crucial as we move forward in our vaccination roll out.